ANNE OJALA: Open Payments
NPI 1215277611 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 8 payments from 6 companies in 2025. Trend: 2023 $473 · 2024 $771 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $120 |
| Janssen Biotech, Inc. | 3 | $59 |
| BTG International Inc. | 1 | $20 |
| Gamida Cell Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
Products named: REZUROCK, TALVEY, VORAXAZE, OMISIRGE, BLENREP, Polivy.
Industry payments across PA — which companies pay providers there.
